Patrick T. Ellinor
Tracked across 1 events · 6 articles · First seen Aug 04, 2026 · Last active Aug 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Patrick T. Ellinor was appointed to the board, bringing expertise in cardiovascular genetics and clinical leadership. His appointment is expected to support Editas' development of EDIT-401 for hyperlipidemia.
Aug 04, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Patrick T. Ellinor live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard